Cowen and Company’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,100
Closed -$2.32K 746
2023
Q4
$2.32K Hold
10,100
﹤0.01% 515
2023
Q3
$1.67K Buy
+10,100
New +$2.33K ﹤0.01% 602
2023
Q2
Sell
-10,387
Closed -$1.02K 653
2023
Q1
$1.02K Buy
10,387
+100
+1% +$7 ﹤0.01% 555
2022
Q4
$617 Sell
10,287
-114,713
-92% -$9.38K ﹤0.01% 640
2022
Q3
$9K Buy
+125,000
New +$12.2K ﹤0.01% 437

Other funds holding AONCW

Cowen and Company's AONCW Position: Q1 2024 in Review

Cowen and Company sold out of American Oncology Network, Inc. Warrant (AONCW) in Q1 2024, closing a stake of 10,100 shares — an estimated $2.32K sold.

Cowen and Company first reported a position in AONCW in Q3 2022 and held it in 5 quarters. The position peaked at $9K in Q3 2022. 33 funds tracked by Wall St. Rank hold AONCW as of Q1 2024.

  • Cowen and Company reported no remaining American Oncology Network, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 10,100 American Oncology Network, Inc. Warrant shares in Q1 2024, an estimated $2.32K.
  • Cowen and Company first reported a position in American Oncology Network, Inc. Warrant in Q3 2022 and held it in 5 quarters.
  • Cowen and Company's American Oncology Network, Inc. Warrant position peaked at $9K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.